23 reports

Key Features of the Report: - Anxiety Disorder Patient Flow - Anxiety Disorder Prevalence - Anxiety Disorder Diagnosed Patients - Anxiety Disorder Treated Patients

  • Anxiety Disorder
  • Europe
  • France
  • World
  • Forecast
  • General Anxiety Disorder Overview
  • General Anxiety Disorder - Dormant Projects
  • Anxiety Disorder
  • United States
  • World
  • Product Initiative
  • H. Lundbeck A/S
  • General Anxiety Disorder Overview
  • General Anxiety Disorder - Therapeutics Assessment
  • Anxiety Disorder
  • United States
  • World
  • Product Initiative
  • H. Lundbeck A/S

Key Features of the Report: - Anxiety Disorder Patient Flow - Anxiety Disorder Prevalence - Anxiety Disorder Diagnosed Patients - Anxiety Disorder Treated Patients

  • Anxiety Disorder
  • Europe
  • France
  • Germany
  • Forecast
  • Anxiety Disorders - Discontinued Products
  • Anxiety Disorders - Dormant Projects
  • Anxiety Disorder
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative

Anxiety disorders and depression treatment market, 2014 - 2025 (USD Million) ##. ##. ## Canada ##. ##. ##. ## Canada anxiety disorders and depression treatment market, 2014 - 2025 (USD Million) ##. ## Europe ##. ##. ## Europe anxiety disorders and depression treatme

  • Antidepressant
  • Anxiety Disorder
  • Therapy
  • Forecast
  • Market Size
  • Anxiety Disorders Overview
  • Anxiety Disorders - Therapeutics Assessment
  • Anxiety Disorder
  • Research And Development
  • United States
  • Company
  • Product Initiative
  • 2.3 UPCOMING REPORTS
  • 4.1 BIBLIOGRAPHY
  • Anxiety Disorder
  • Germany
  • United States
  • World
  • Forecast
  • Global Anxiety Disorders Market
  • 06. Types of Anxiety Disorders
  • Anxiety Disorder
  • World
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • Pfizer Inc.

Generalized Anxiety Disorder - Market Overview ##.

  • Anxiety Disorder
  • Mental Health
  • Pathology
  • Therapy
  • North America
  • Key clinical trial approval
  • 11.1 Factors impacting market growth
  • Anxiety Disorder
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • AUG 01, 2017: CATASYS ANNOUNCES PROGRAM EXPANSION WITH LEADING NATIONAL HEALTH INSURANCE PLAN TO INCLUDE ANXIETY DISORDER
  • JUL 06, 2016: CATASYS EXPANDS ROLLOUT OF ONTRAK-H SOLUTION IN VIRGINIA WITH LEADING NATIONAL HEALTH INSURANCE PROVIDER
  • Anxiety Disorder
  • Healthcare
  • United States
  • Company Financials
  • Catasys, Inc.
  • SYNTHETIC PEPTIDE TO TARGET NPSR FOR ANXIETY DISORDER - DRUG PROFILE
  • INV-107 - DRUG PROFILE
  • Anxiety Disorder
  • United States
  • Company
  • Product Initiative
  • Tonix Pharmaceuticals Holding Corp.
  • SYNTHETIC PEPTIDE TO TARGET NPSR FOR ANXIETY DISORDER - DRUG PROFILE
  • R&D Progress
  • Anxiety Disorder
  • Pharmaceutical
  • United States
  • Product Initiative
  • Tonix Pharmaceuticals Holding Corp.
  • Clinical Trial profile. 13 Trial Title
  • Target
  • Anxiety Disorder
  • Hormone
  • World
  • Product Initiative
  • Torrent
  • PIPELINE BY BIONOMICS LTD, H2 2017
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H2 2017
  • Anxiety Disorder
  • Therapy
  • United States
  • Product Initiative
  • Bionomics
  • SAINT SYSTEM - ANXIETY DISORDERS
  • SAINT SYSTEM - ANXIETY DISORDERS - PRODUCT STATUS
  • Anxiety Disorder
  • Chronic Pain
  • United States
  • Product Initiative
  • MicroTransponder, Inc.
  • Clinical Trial profile. 15 Trial Title
  • Target
  • Anxiety Disorder
  • Hormone
  • Mental Health
  • World
  • Product Initiative

Anxiety Disorders, Diabetic Neuropathic Pain, Fibromyalgia, Generalized Anxiety Disorder (GAD), Major Depressive Disorder, Musculoskeletal Pain, Peripheral Neuropathic Pain Completed Phase I Interventional duloxetine hydrochloride DR Dr.

  • Anxiety Disorder
  • Chronic Pain
  • Clinical Trial
  • Pharmaceutical
  • Eli Lilly & Co.
  • Target
  • Target
  • Anxiety Disorder
  • Mental Health
  • Pathology
  • World
  • Product Initiative
  • Clinical Trial profile. 153 Trial Title
  • Clinical Trial profile. 75 Trial Title
  • Anxiety Disorder
  • Clinical Trial
  • Pharmaceutical
  • United States
  • World
  • Clinical Trial profile. 26 Trial Title
  • Clinical Trial profile. 34 Trial Title

Premenstrual Dysphoric Disorder (PMDD) Global Clinical Trials Review, H##, 2015 Reference Code: GDHC##CTIDB Publication Date: DEC 2015 LIST OF TABLES LIST OF FIGURES Premenstrual Dysphoric Disorder (PMDD) Global Clinical Trials Review, H##, 2015 outlines clinical trials in Premenst

  • Anxiety Disorder
  • Therapy
  • World
  • Product Initiative
  • Pfizer Inc.
  • 09.1 MARKET OVERVIEW
  • 07.7 EPIDEMIOLOGY
  • Anxiety Disorder
  • Azevan Pharmaceuticals, Inc.
  • GlaxoSmithKline plc
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.